Answers are grounded in this paper and cite their sources.
AMA Graczyk M, Pawlak Ł, Lewandowska AA. Is there a place for cannabigerol in symptomatic treatment?. Medycyna Paliatywna/Palliative Medicine. 2023. doi:10.5114/pm.2023.131449. APA Graczyk, M., Pawlak, Ł., & Lewandowska, A. A. (2023). Is there a place for cannabigerol in symptomatic treatment?. Medycyna Paliatywna/Palliative Medicine. https://doi.org/10.5114/pm.2023.131449 Chicago Graczyk, Michał, Łukasz Pawlak, and Agata A Lewandowska. 2023. "Is there a place for cannabigerol in symptomatic treatment?". Medycyna Paliatywna/Palliative Medicine. doi:10.5114/pm.2023.131449. Harvard Graczyk, M., Pawlak, Ł., and Lewandowska, A. (2023). Is there a place for cannabigerol in symptomatic treatment?. Medycyna Paliatywna/Palliative Medicine. https://doi.org/10.5114/pm.2023.131449 MLA Graczyk, Michał et al. "Is there a place for cannabigerol in symptomatic treatment?." Medycyna Paliatywna/Palliative Medicine, 2023. doi:10.5114/pm.2023.131449. Vancouver Graczyk M, Pawlak Ł, Lewandowska A. Is there a place for cannabigerol in symptomatic treatment?. Medycyna Paliatywna/Palliative Medicine. 2023. doi:10.5114/pm.2023.131449.
No takes yet. Share an insight, caveat, or question.
Graczyk et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: